COLUMBIA, Md., Nov. 5 /PRNewswire-FirstCall/ -- Already a leader in the DHA omega-3 food and supplements industries, Martek Biosciences Corporation announced today that it will be expanding its reach in the animal feed market with a worldwide exclusive distributorship agreement for its DHA Gold(R) product with Novus International, Inc. Martek will serve as Novus's exclusive worldwide DHA supplier for all of its poultry and swine feed and enrichment products. All Novus products containing DHA Gold(R) will display the DHA Gold(R) trademark.
"This partnership with Novus represents a new opportunity for Martek," said Joe Buron, vice president of sales and marketing for Martek. "Animal feed and nutrition represent a logical extension of Martek's core technology and we are pleased to be working with an industry leader and innovator like Novus as we expand into this market."
DHA Gold(R) biomass animal feed ingredient is a dried, whole-cell algae product used to provide DHA enrichment for commercially raised animals. Adding DHA Gold(R) to animal feed is a safe and effective way to enrich foods such as meat, eggs and milk. DHA Gold(R) is unique in the market because it is from a sustainable and vegetarian source, has a more stable and consistent composition than fish oil and fish byproducts, and is free of ocean-borne contaminants.
Novus International, Inc. is headquartered in St. Louis, Missouri, U.S.A. and serves customers in more than 80 countries around the world. An industry leader in animal nutrition and health, Novus products include ALIMET(R) and MHA(R) feed supplements, ACTIVATE(R) nutritional feed acid, ACIDOMIX(TM) preservative premixture, ADVENT(R) coccidiosis control, MINTREX(R) organic trace minerals, SANTOQUIN(R) feed preservative and many other specialty ingredients. Arenus (http://www.arenusperformance.com), part of Novus International, Inc., focuses on developing performance products for the equine, canine, and human markets. Novus is privately owned by Mitsui and Co., Ltd. and Nippon Soda Co., Ltd. For more information visit http://www.novusint.com.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM) (http://www.lifesdha.com), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements, and DHAGold(R), a sustainable and vegetarian source of DHA for animal feed. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.
|SOURCE Martek Biosciences Corporation|
Copyright©2007 PR Newswire.
All rights reserved